These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20393721)

  • 1. [Female patient with Muir-Torre syndrome].
    Negraszus N; Jöhrens K; Bertelmann E
    Ophthalmologe; 2010 Nov; 107(11):1059-62. PubMed ID: 20393721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muir-Torre Syndrome Masquerading as Chalazion.
    Makrygiannis G; Vahdani K; Giasin O
    Ophthalmic Plast Reconstr Surg; 2015; 31(5):422-3. PubMed ID: 26352527
    [No Abstract]   [Full Text] [Related]  

  • 3. DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma.
    Rajan Kd A; Burris C; Iliff N; Grant M; Eshleman JR; Eberhart CG
    Am J Ophthalmol; 2014 Mar; 157(3):640-7.e1-2. PubMed ID: 24321472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying Muir-Torre syndrome in a patient with glioblastoma multiforme.
    Park DM; Yeaney GA; Hamilton RL; Mabold J; Urban N; Appleman L; Flickinger J; Lieberman F; Mintz A
    Neuro Oncol; 2009 Aug; 11(4):452-5. PubMed ID: 19028998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy.
    Ponti G; Meschieri A; Pollio A; Ruini C; Manfredini M; Longo C; Mandel VD; Ciardo S; Tomasi A; Giannetti L; Pellacani G
    J Oral Pathol Med; 2015 Aug; 44(7):552-7. PubMed ID: 25213213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry screening of sebaceous lesions for Muir-Torre syndrome in a 26-year period in a Mexican population.
    Archer-Dubon C; Alvarez-Zavala B; Reyes E; Orozco-Topete R
    Dermatol Online J; 2008 Dec; 14(12):1. PubMed ID: 19265614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of DNA mismatch repair genes in the diagnosis and management of periocular sebaceous cell carcinoma and Muir-Torre syndrome.
    Gaskin BJ; Fernando BS; Sullivan CA; Whitehead K; Sullivan TJ
    Br J Ophthalmol; 2011 Dec; 95(12):1686-90. PubMed ID: 21979897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sebaceous adenomas of the eyelid and Muir-Torre Syndrome.
    Jagan L; Zoroquiain P; Bravo-Filho V; Logan P; Qutub M; Burnier MN
    Br J Ophthalmol; 2015 Jul; 99(7):909-13. PubMed ID: 25595178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muir-Torre Syndrome / Turcot Syndrome overlap? A patient with sebaceous carcinoma, colon cancer, and a malignant astrocytoma.
    Kleinerman R; Marino J; Loucas E
    Dermatol Online J; 2012 May; 18(5):3. PubMed ID: 22630573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sebaceous tumors and Muir-Torre syndrome].
    Bourlond F; Cribier B; Lipsker D; Velter C
    Ann Dermatol Venereol; 2015; 142(6-7):456-9. PubMed ID: 25890836
    [No Abstract]   [Full Text] [Related]  

  • 11. Muir-Torre Syndrome: expanding the genotype and phenotype--a further family with a MSH6 mutation.
    Murphy HR; Armstrong R; Cairns D; Greenhalgh KL
    Fam Cancer; 2008; 7(3):255-7. PubMed ID: 18236172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synchronous gastric and sebaceous cancers, a rare manifestation of MLH1-related Muir-Torre syndrome.
    Svec J; Schwarzová L; Janošíková B; Stekrová J; Mandys V; Kment M; Vodička P
    Int J Clin Exp Pathol; 2014; 7(8):5196-202. PubMed ID: 25197397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of immunohistochemistry in the Muir-Torre Syndrome.
    Oliveira CM; Campos JG; Maia MR; Lobo LE; Valle FF
    An Bras Dermatol; 2015; 90(3 Suppl 1):168-70. PubMed ID: 26312706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal immunohistochemical screening of sebaceous neoplasms for Muir-Torre syndrome: Putting the cart before the horse?
    Kim RH; Nagler AR; Meehan SA
    J Am Acad Dermatol; 2016 Nov; 75(5):1078-1079. PubMed ID: 27745640
    [No Abstract]   [Full Text] [Related]  

  • 15. Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge.
    Ponti G; Manfredini M; Tomasi A; Pellacani G
    Gene; 2016 Sep; 589(2):127-32. PubMed ID: 26143115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroperitoneal undifferentiated pleomorphic sarcoma having microsatellite instability associated with Muir-Torre syndrome: case report and review of literature.
    Lee N; Luthra R; Lopez-Terrada D; Wang WL; Lazar AJ
    J Cutan Pathol; 2013 Aug; 40(8):730-3. PubMed ID: 23672746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muir-Torre syndrome or phenocopy? The value of the immunohistochemical expression of mismatch repair proteins in sebaceous tumors of immunocompromised patients.
    Ponti G; Pellacani G; Ruini C; Percesepe A; Longo C; Mandel VD; Crucianelli F; Gorelli G; Tomasi A
    Fam Cancer; 2014 Dec; 13(4):553-61. PubMed ID: 24969397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sebaceous adenomas in the absence of Muir-Torre syndrome.
    Sia PI; Rajak S; James C; Huilgol S; Selva D
    Can J Ophthalmol; 2016 Oct; 51(5):e152-e153. PubMed ID: 27769341
    [No Abstract]   [Full Text] [Related]  

  • 19. An Intrapatient Concordance Study of Mismatch Repair Protein Immunohistochemical Staining Patterns in Patients With Muir-Torre Syndrome.
    Nguyen CV; Gaddis KJ; Stephens MR; Seykora JT; Chu EY
    JAMA Dermatol; 2020 Jun; 156(6):676-680. PubMed ID: 32267475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Sebaceous Neoplasms for DNA Mismatch Repair Proteins in Muir-Torre Syndrome.
    Pollinger TH; Kieliszak CR; Logemann N; Gratrix ML
    Skinmed; 2017; 15(4):259-264. PubMed ID: 28859734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.